nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenobarbital—GABRA4—autistic disorder	0.112	0.147	CbGaD
Methylphenobarbital—CHRNA7—autistic disorder	0.105	0.137	CbGaD
Methylphenobarbital—GABRA5—autistic disorder	0.0999	0.131	CbGaD
Methylphenobarbital—GRIK2—autistic disorder	0.0981	0.128	CbGaD
Methylphenobarbital—GABRA3—autistic disorder	0.0981	0.128	CbGaD
Methylphenobarbital—GABRA1—autistic disorder	0.0857	0.112	CbGaD
Methylphenobarbital—CHRNA4—autistic disorder	0.0839	0.11	CbGaD
Methylphenobarbital—GABRA2—autistic disorder	0.0819	0.107	CbGaD
Methylphenobarbital—GRIK2—cerebellar cortex—autistic disorder	0.00653	0.089	CbGeAlD
Methylphenobarbital—GRIK2—telencephalic ventricle—autistic disorder	0.0038	0.0518	CbGeAlD
Methylphenobarbital—CHRNA4—telencephalic ventricle—autistic disorder	0.00305	0.0416	CbGeAlD
Methylphenobarbital—GRIA2—hindbrain—autistic disorder	0.00199	0.0271	CbGeAlD
Methylphenobarbital—GABRA6—hindbrain—autistic disorder	0.00192	0.0261	CbGeAlD
Methylphenobarbital—GRIK2—hindbrain—autistic disorder	0.00179	0.0244	CbGeAlD
Methylphenobarbital—CHRNA4—hindbrain—autistic disorder	0.00144	0.0196	CbGeAlD
Methylphenobarbital—GABRA2—hindbrain—autistic disorder	0.00129	0.0176	CbGeAlD
Methylphenobarbital—GABRA1—hindbrain—autistic disorder	0.00125	0.017	CbGeAlD
Methylphenobarbital—GRIA2—brainstem—autistic disorder	0.00114	0.0155	CbGeAlD
Methylphenobarbital—GABRA6—brainstem—autistic disorder	0.0011	0.015	CbGeAlD
Methylphenobarbital—GRIA2—forebrain—autistic disorder	0.0011	0.015	CbGeAlD
Methylphenobarbital—GABRA5—forebrain—autistic disorder	0.00103	0.014	CbGeAlD
Methylphenobarbital—GRIK2—brainstem—autistic disorder	0.00103	0.014	CbGeAlD
Methylphenobarbital—GRIA2—telencephalon—autistic disorder	0.00101	0.0138	CbGeAlD
Methylphenobarbital—GRIK2—eye—autistic disorder	0.001	0.0136	CbGeAlD
Methylphenobarbital—CHRFAM7A—forebrain—autistic disorder	0.001	0.0136	CbGeAlD
Methylphenobarbital—GRIK2—forebrain—autistic disorder	0.000992	0.0135	CbGeAlD
Methylphenobarbital—GABRA6—telencephalon—autistic disorder	0.000976	0.0133	CbGeAlD
Methylphenobarbital—GABRA5—telencephalon—autistic disorder	0.000947	0.0129	CbGeAlD
Methylphenobarbital—GABRA4—forebrain—autistic disorder	0.000934	0.0127	CbGeAlD
Methylphenobarbital—CHRFAM7A—telencephalon—autistic disorder	0.00092	0.0125	CbGeAlD
Methylphenobarbital—GRIK2—telencephalon—autistic disorder	0.000912	0.0124	CbGeAlD
Methylphenobarbital—GABRA4—telencephalon—autistic disorder	0.000859	0.0117	CbGeAlD
Methylphenobarbital—CHRNA4—brainstem—autistic disorder	0.000826	0.0113	CbGeAlD
Methylphenobarbital—CHRNA7—eye—autistic disorder	0.000815	0.0111	CbGeAlD
Methylphenobarbital—CHRNA7—forebrain—autistic disorder	0.000808	0.011	CbGeAlD
Methylphenobarbital—CHRNA4—forebrain—autistic disorder	0.000797	0.0109	CbGeAlD
Methylphenobarbital—CHRNA7—telencephalon—autistic disorder	0.000743	0.0101	CbGeAlD
Methylphenobarbital—GABRA2—brainstem—autistic disorder	0.00074	0.0101	CbGeAlD
Methylphenobarbital—CHRNA4—telencephalon—autistic disorder	0.000733	0.00999	CbGeAlD
Methylphenobarbital—GABRA1—brainstem—autistic disorder	0.000715	0.00974	CbGeAlD
Methylphenobarbital—GABRA2—forebrain—autistic disorder	0.000714	0.00972	CbGeAlD
Methylphenobarbital—GABRA1—forebrain—autistic disorder	0.00069	0.0094	CbGeAlD
Methylphenobarbital—GABRA2—telencephalon—autistic disorder	0.000656	0.00894	CbGeAlD
Methylphenobarbital—GABRA1—telencephalon—autistic disorder	0.000634	0.00864	CbGeAlD
Methylphenobarbital—GRIA2—head—autistic disorder	0.000629	0.00857	CbGeAlD
Methylphenobarbital—GABRA6—head—autistic disorder	0.000608	0.00828	CbGeAlD
Methylphenobarbital—GRIA2—nervous system—autistic disorder	0.000596	0.00812	CbGeAlD
Methylphenobarbital—GABRA5—head—autistic disorder	0.000589	0.00803	CbGeAlD
Methylphenobarbital—GABRA6—nervous system—autistic disorder	0.000576	0.00785	CbGeAlD
Methylphenobarbital—GRIA2—central nervous system—autistic disorder	0.000574	0.00782	CbGeAlD
Methylphenobarbital—CHRFAM7A—head—autistic disorder	0.000573	0.00781	CbGeAlD
Methylphenobarbital—GRIK2—head—autistic disorder	0.000568	0.00774	CbGeAlD
Methylphenobarbital—CHRNA7—digestive system—autistic disorder	0.000567	0.00773	CbGeAlD
Methylphenobarbital—GRIA2—cerebellum—autistic disorder	0.000561	0.00764	CbGeAlD
Methylphenobarbital—CHRNA4—digestive system—autistic disorder	0.00056	0.00763	CbGeAlD
Methylphenobarbital—GABRA5—nervous system—autistic disorder	0.000559	0.00761	CbGeAlD
Methylphenobarbital—GABRA6—central nervous system—autistic disorder	0.000555	0.00756	CbGeAlD
Methylphenobarbital—GABRA3—head—autistic disorder	0.000549	0.00748	CbGeAlD
Methylphenobarbital—CHRFAM7A—nervous system—autistic disorder	0.000543	0.0074	CbGeAlD
Methylphenobarbital—GABRA6—cerebellum—autistic disorder	0.000542	0.00739	CbGeAlD
Methylphenobarbital—GRIK2—nervous system—autistic disorder	0.000539	0.00734	CbGeAlD
Methylphenobarbital—GABRA5—central nervous system—autistic disorder	0.000538	0.00733	CbGeAlD
Methylphenobarbital—GABRA4—head—autistic disorder	0.000535	0.00729	CbGeAlD
Methylphenobarbital—CHRFAM7A—central nervous system—autistic disorder	0.000523	0.00713	CbGeAlD
Methylphenobarbital—GABRA3—nervous system—autistic disorder	0.00052	0.00709	CbGeAlD
Methylphenobarbital—GRIK2—central nervous system—autistic disorder	0.000519	0.00707	CbGeAlD
Methylphenobarbital—Ethotoin—SCN7A—autistic disorder	0.000512	0.0759	CrCbGaD
Methylphenobarbital—GABRA4—nervous system—autistic disorder	0.000507	0.00691	CbGeAlD
Methylphenobarbital—GRIK2—cerebellum—autistic disorder	0.000507	0.00691	CbGeAlD
Methylphenobarbital—GABRA3—central nervous system—autistic disorder	0.000501	0.00682	CbGeAlD
Methylphenobarbital—GABRA4—central nervous system—autistic disorder	0.000488	0.00665	CbGeAlD
Methylphenobarbital—GABRA4—cerebellum—autistic disorder	0.000477	0.0065	CbGeAlD
Methylphenobarbital—CHRNA7—head—autistic disorder	0.000463	0.00631	CbGeAlD
Methylphenobarbital—CHRNA4—head—autistic disorder	0.000457	0.00622	CbGeAlD
Methylphenobarbital—GRIA2—brain—autistic disorder	0.000456	0.00621	CbGeAlD
Methylphenobarbital—GABRA6—brain—autistic disorder	0.00044	0.006	CbGeAlD
Methylphenobarbital—CHRNA7—nervous system—autistic disorder	0.000439	0.00598	CbGeAlD
Methylphenobarbital—CHRNA4—nervous system—autistic disorder	0.000433	0.0059	CbGeAlD
Methylphenobarbital—GABRA5—brain—autistic disorder	0.000427	0.00582	CbGeAlD
Methylphenobarbital—CHRNA7—central nervous system—autistic disorder	0.000422	0.00576	CbGeAlD
Methylphenobarbital—CHRNA4—central nervous system—autistic disorder	0.000417	0.00568	CbGeAlD
Methylphenobarbital—CHRFAM7A—brain—autistic disorder	0.000415	0.00566	CbGeAlD
Methylphenobarbital—GRIK2—brain—autistic disorder	0.000412	0.00561	CbGeAlD
Methylphenobarbital—GABRA2—head—autistic disorder	0.000409	0.00557	CbGeAlD
Methylphenobarbital—CHRNA4—cerebellum—autistic disorder	0.000407	0.00555	CbGeAlD
Methylphenobarbital—GABRA3—brain—autistic disorder	0.000398	0.00542	CbGeAlD
Methylphenobarbital—Methsuximide—CACNA1H—autistic disorder	0.000397	0.0588	CrCbGaD
Methylphenobarbital—GABRA1—head—autistic disorder	0.000395	0.00538	CbGeAlD
Methylphenobarbital—GABRA4—brain—autistic disorder	0.000388	0.00528	CbGeAlD
Methylphenobarbital—GABRA2—nervous system—autistic disorder	0.000387	0.00528	CbGeAlD
Methylphenobarbital—Phensuximide—CACNA1H—autistic disorder	0.000385	0.057	CrCbGaD
Methylphenobarbital—GABRA1—nervous system—autistic disorder	0.000374	0.0051	CbGeAlD
Methylphenobarbital—GABRA2—central nervous system—autistic disorder	0.000373	0.00508	CbGeAlD
Methylphenobarbital—CYP2C19—digestive system—autistic disorder	0.000365	0.00497	CbGeAlD
Methylphenobarbital—GABRA2—cerebellum—autistic disorder	0.000365	0.00497	CbGeAlD
Methylphenobarbital—GABRA1—central nervous system—autistic disorder	0.000361	0.00491	CbGeAlD
Methylphenobarbital—GABRA1—cerebellum—autistic disorder	0.000352	0.0048	CbGeAlD
Methylphenobarbital—CHRNA7—brain—autistic disorder	0.000335	0.00457	CbGeAlD
Methylphenobarbital—CHRNA4—brain—autistic disorder	0.000331	0.00451	CbGeAlD
Methylphenobarbital—Methohexital—GABRB3—autistic disorder	0.000325	0.0481	CrCbGaD
Methylphenobarbital—Hexobarbital—GABRA4—autistic disorder	0.000318	0.0471	CrCbGaD
Methylphenobarbital—Hexobarbital—CHRNA7—autistic disorder	0.000297	0.044	CrCbGaD
Methylphenobarbital—GABRA2—brain—autistic disorder	0.000296	0.00403	CbGeAlD
Methylphenobarbital—GABRA1—brain—autistic disorder	0.000286	0.0039	CbGeAlD
Methylphenobarbital—CYP2B6—digestive system—autistic disorder	0.000285	0.00389	CbGeAlD
Methylphenobarbital—Hexobarbital—GABRA5—autistic disorder	0.000282	0.0419	CrCbGaD
Methylphenobarbital—Methohexital—GABRA1—autistic disorder	0.000279	0.0413	CrCbGaD
Methylphenobarbital—Hexobarbital—GABRA3—autistic disorder	0.000277	0.0411	CrCbGaD
Methylphenobarbital—Hexobarbital—GRIK2—autistic disorder	0.000277	0.0411	CrCbGaD
Methylphenobarbital—Glutethimide—GABRB3—autistic disorder	0.000253	0.0374	CrCbGaD
Methylphenobarbital—Hexobarbital—GABRA1—autistic disorder	0.000242	0.0359	CrCbGaD
Methylphenobarbital—Hexobarbital—CHRNA4—autistic disorder	0.000237	0.0352	CrCbGaD
Methylphenobarbital—CYP2B6—head—autistic disorder	0.000233	0.00317	CbGeAlD
Methylphenobarbital—Hexobarbital—GABRA2—autistic disorder	0.000232	0.0343	CrCbGaD
Methylphenobarbital—CYP2B6—nervous system—autistic disorder	0.000221	0.00301	CbGeAlD
Methylphenobarbital—Glutethimide—GABRA1—autistic disorder	0.000217	0.0321	CrCbGaD
Methylphenobarbital—CYP2B6—central nervous system—autistic disorder	0.000213	0.0029	CbGeAlD
Methylphenobarbital—Pethidine—GRIN2A—autistic disorder	0.000207	0.0307	CrCbGaD
Methylphenobarbital—Primidone—GABRA4—autistic disorder	0.000184	0.0273	CrCbGaD
Methylphenobarbital—Primidone—CHRNA7—autistic disorder	0.000172	0.0255	CrCbGaD
Methylphenobarbital—CYP2B6—brain—autistic disorder	0.000169	0.0023	CbGeAlD
Methylphenobarbital—Primidone—GABRA5—autistic disorder	0.000164	0.0243	CrCbGaD
Methylphenobarbital—Primidone—GRIK2—autistic disorder	0.000161	0.0238	CrCbGaD
Methylphenobarbital—Primidone—GABRA3—autistic disorder	0.000161	0.0238	CrCbGaD
Methylphenobarbital—Primidone—GABRB2—autistic disorder	0.000143	0.0212	CrCbGaD
Methylphenobarbital—Primidone—GABRA1—autistic disorder	0.00014	0.0208	CrCbGaD
Methylphenobarbital—Primidone—CHRNA4—autistic disorder	0.000137	0.0204	CrCbGaD
Methylphenobarbital—Primidone—GABRA2—autistic disorder	0.000134	0.0199	CrCbGaD
Methylphenobarbital—Pethidine—OPRM1—autistic disorder	0.000113	0.0168	CrCbGaD
Methylphenobarbital—Phenobarbital—CHRNA7—autistic disorder	0.000109	0.0161	CrCbGaD
Methylphenobarbital—Phenobarbital—GRIK2—autistic disorder	0.000101	0.015	CrCbGaD
Methylphenobarbital—Phenobarbital—GABRA1—autistic disorder	8.87e-05	0.0131	CrCbGaD
Methylphenobarbital—Phenobarbital—CHRNA4—autistic disorder	8.68e-05	0.0129	CrCbGaD
Methylphenobarbital—Pethidine—SLC6A4—autistic disorder	6.23e-05	0.00923	CrCbGaD
Methylphenobarbital—Antipyrine—PTGS2—autistic disorder	5.31e-05	0.00788	CrCbGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—SLC1A3—autistic disorder	2.38e-05	0.000153	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—MAOA—autistic disorder	2.37e-05	0.000153	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—COMT—autistic disorder	2.36e-05	0.000152	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—SLC1A3—autistic disorder	2.35e-05	0.000151	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—AQP4—autistic disorder	2.35e-05	0.000151	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—MAOA—autistic disorder	2.34e-05	0.000151	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—GABRA2—autistic disorder	2.34e-05	0.000151	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—GABRB2—autistic disorder	2.34e-05	0.000151	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—MAOB—autistic disorder	2.32e-05	0.000149	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—GABRA2—autistic disorder	2.3e-05	0.000148	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—GABRB2—autistic disorder	2.3e-05	0.000148	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—GABRB1—autistic disorder	2.26e-05	0.000146	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—GABRA3—autistic disorder	2.26e-05	0.000146	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—GABRA5—autistic disorder	2.26e-05	0.000146	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—GABRA4—autistic disorder	2.26e-05	0.000146	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—SLC40A1—autistic disorder	2.26e-05	0.000146	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—GABRB2—autistic disorder	2.26e-05	0.000146	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—COMT—autistic disorder	2.25e-05	0.000145	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—MAOA—autistic disorder	2.23e-05	0.000144	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—HTR2A—autistic disorder	2.22e-05	0.000143	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—PRKCB—autistic disorder	2.21e-05	0.000143	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—PRKCB—autistic disorder	2.18e-05	0.000141	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—GABRB3—autistic disorder	2.17e-05	0.00014	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—autistic disorder	2.17e-05	0.00014	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—autistic disorder	2.12e-05	0.000137	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—CP—autistic disorder	2.12e-05	0.000137	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—DLG4—autistic disorder	2.1e-05	0.000136	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Phase 1 - Functionalization of compounds—POMC—autistic disorder	2.1e-05	0.000136	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—COMT—autistic disorder	2.1e-05	0.000135	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—CP—autistic disorder	2.09e-05	0.000135	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—SLC1A3—autistic disorder	2.09e-05	0.000135	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—AQP4—autistic disorder	2.09e-05	0.000135	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—MAOA—autistic disorder	2.08e-05	0.000134	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—COMT—autistic disorder	2.06e-05	0.000133	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—SLC1A3—autistic disorder	2.05e-05	0.000132	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—AQP4—autistic disorder	2.05e-05	0.000132	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—MAOA—autistic disorder	2.04e-05	0.000132	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—PRKCB—autistic disorder	2.04e-05	0.000131	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—COMT—autistic disorder	2.02e-05	0.00013	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—AQP4—autistic disorder	2.01e-05	0.00013	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—SLC1A3—autistic disorder	2.01e-05	0.00013	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—MAOA—autistic disorder	2.01e-05	0.00013	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—PRKCB—autistic disorder	1.98e-05	0.000128	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—autistic disorder	1.96e-05	0.000126	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—PRKCB—autistic disorder	1.94e-05	0.000125	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—GABRA2—autistic disorder	1.93e-05	0.000124	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—GABRB2—autistic disorder	1.93e-05	0.000124	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—autistic disorder	1.91e-05	0.000123	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—PRKCB—autistic disorder	1.91e-05	0.000123	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—PRKCB—autistic disorder	1.87e-05	0.000121	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—CP—autistic disorder	1.86e-05	0.00012	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—CYP19A1—autistic disorder	1.86e-05	0.00012	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—CYP19A1—autistic disorder	1.83e-05	0.000118	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—CP—autistic disorder	1.83e-05	0.000118	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—autistic disorder	1.82e-05	0.000118	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Arachidonic acid metabolism—PTGS2—autistic disorder	1.81e-05	0.000117	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—TF—autistic disorder	1.8e-05	0.000116	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—CP—autistic disorder	1.79e-05	0.000116	CbGpPWpGaD
Methylphenobarbital—GRIK2—Transmission across Chemical Synapses—MAPK1—autistic disorder	1.79e-05	0.000116	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—DHCR7—autistic disorder	1.79e-05	0.000115	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—MAPK1—autistic disorder	1.78e-05	0.000115	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—TF—autistic disorder	1.78e-05	0.000115	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—autistic disorder	1.77e-05	0.000114	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—autistic disorder	1.74e-05	0.000112	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—COMT—autistic disorder	1.73e-05	0.000111	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—COMT—autistic disorder	1.72e-05	0.000111	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—GSTP1—autistic disorder	1.72e-05	0.000111	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—SLC1A3—autistic disorder	1.72e-05	0.000111	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—AQP4—autistic disorder	1.72e-05	0.000111	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—MAOA—autistic disorder	1.71e-05	0.000111	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—MAOA—autistic disorder	1.71e-05	0.00011	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—COMT—autistic disorder	1.7e-05	0.00011	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—PRKCB—autistic disorder	1.69e-05	0.000109	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—GSTP1—autistic disorder	1.69e-05	0.000109	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—PRKCB—autistic disorder	1.67e-05	0.000108	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Transmission across Chemical Synapses—MAPK1—autistic disorder	1.63e-05	0.000105	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—PRKCB—autistic disorder	1.6e-05	0.000103	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Phase 1 - Functionalization of compounds—POMC—autistic disorder	1.59e-05	0.000102	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—TF—autistic disorder	1.58e-05	0.000102	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—GSTM1—autistic disorder	1.58e-05	0.000102	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—GSTM1—autistic disorder	1.56e-05	0.0001	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—TF—autistic disorder	1.55e-05	0.0001	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—CP—autistic disorder	1.53e-05	9.87e-05	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—autistic disorder	1.53e-05	9.86e-05	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—TF—autistic disorder	1.53e-05	9.84e-05	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—autistic disorder	1.52e-05	9.78e-05	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—autistic disorder	1.5e-05	9.66e-05	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—PRKCB—autistic disorder	1.49e-05	9.59e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—INPP1—autistic disorder	1.48e-05	9.53e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—ACADSB—autistic disorder	1.48e-05	9.53e-05	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—autistic disorder	1.46e-05	9.44e-05	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—PRKCB—autistic disorder	1.46e-05	9.42e-05	CbGpPWpGaD
Methylphenobarbital—GRIK2—Transmission across Chemical Synapses—HRAS—autistic disorder	1.44e-05	9.28e-05	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—PRKCB—autistic disorder	1.43e-05	9.26e-05	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—HRAS—autistic disorder	1.43e-05	9.23e-05	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—autistic disorder	1.42e-05	9.16e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—CYP19A1—autistic disorder	1.4e-05	9.05e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—CYP19A1—autistic disorder	1.38e-05	8.93e-05	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neuronal System—MAPK1—autistic disorder	1.37e-05	8.86e-05	CbGpPWpGaD
Methylphenobarbital—GRIA2—Transmission across Chemical Synapses—MAPK1—autistic disorder	1.37e-05	8.84e-05	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—autistic disorder	1.33e-05	8.58e-05	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—MAPK1—autistic disorder	1.33e-05	8.57e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—BTD—autistic disorder	1.32e-05	8.5e-05	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Transmission across Chemical Synapses—HRAS—autistic disorder	1.31e-05	8.44e-05	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—autistic disorder	1.31e-05	8.42e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—COMT—autistic disorder	1.3e-05	8.42e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—TF—autistic disorder	1.3e-05	8.39e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—GSTP1—autistic disorder	1.3e-05	8.38e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—MAOA—autistic disorder	1.3e-05	8.36e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—COMT—autistic disorder	1.29e-05	8.3e-05	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—autistic disorder	1.28e-05	8.28e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—GSTP1—autistic disorder	1.28e-05	8.26e-05	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—AVP—autistic disorder	1.25e-05	8.06e-05	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—MAPK1—autistic disorder	1.25e-05	8.06e-05	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—autistic disorder	1.25e-05	8.04e-05	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—AVP—autistic disorder	1.23e-05	7.96e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—PRKCB—autistic disorder	1.22e-05	7.89e-05	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—autistic disorder	1.22e-05	7.85e-05	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—autistic disorder	1.2e-05	7.75e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—GSTM1—autistic disorder	1.19e-05	7.7e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—GSTM1—autistic disorder	1.18e-05	7.59e-05	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—MAPK1—autistic disorder	1.14e-05	7.35e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—NPAS2—autistic disorder	1.13e-05	7.29e-05	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—MAPK1—autistic disorder	1.13e-05	7.26e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—TDO2—autistic disorder	1.12e-05	7.22e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—INPP1—autistic disorder	1.12e-05	7.2e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—ACADSB—autistic disorder	1.12e-05	7.2e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—POMC—autistic disorder	1.12e-05	7.2e-05	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neuronal System—HRAS—autistic disorder	1.1e-05	7.11e-05	CbGpPWpGaD
Methylphenobarbital—GRIA2—Transmission across Chemical Synapses—HRAS—autistic disorder	1.1e-05	7.1e-05	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—AVP—autistic disorder	1.1e-05	7.07e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—autistic disorder	1.09e-05	7.06e-05	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—AVP—autistic disorder	1.08e-05	6.94e-05	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—autistic disorder	1.07e-05	6.89e-05	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—HRAS—autistic disorder	1.07e-05	6.88e-05	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—AVP—autistic disorder	1.06e-05	6.82e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—DHCR7—autistic disorder	1.05e-05	6.79e-05	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—MAPK1—autistic disorder	1.05e-05	6.77e-05	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—autistic disorder	1.05e-05	6.76e-05	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—autistic disorder	1.03e-05	6.65e-05	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—MAPK1—autistic disorder	1.02e-05	6.57e-05	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—HRAS—autistic disorder	1e-05	6.47e-05	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—MAPK1—autistic disorder	1e-05	6.45e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—EXT1—autistic disorder	9.98e-06	6.44e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—SLC6A8—autistic disorder	9.98e-06	6.44e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—BTD—autistic disorder	9.95e-06	6.42e-05	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—MAPK1—autistic disorder	9.82e-06	6.33e-05	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—MAPK1—autistic disorder	9.65e-06	6.22e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—DAO—autistic disorder	9.52e-06	6.14e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—RORA—autistic disorder	9.49e-06	6.12e-05	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—HRAS—autistic disorder	9.15e-06	5.9e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—UPB1—autistic disorder	9.13e-06	5.89e-05	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—HRAS—autistic disorder	9.03e-06	5.83e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—AVP—autistic disorder	9.02e-06	5.82e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—autistic disorder	8.78e-06	5.67e-05	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—MAPK1—autistic disorder	8.73e-06	5.63e-05	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—MAPK1—autistic disorder	8.62e-06	5.56e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—ASMT—autistic disorder	8.48e-06	5.47e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GSTM5—autistic disorder	8.48e-06	5.47e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—TDO2—autistic disorder	8.46e-06	5.46e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—POMC—autistic disorder	8.43e-06	5.44e-05	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—HRAS—autistic disorder	8.43e-06	5.44e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—MAPK1—autistic disorder	8.23e-06	5.31e-05	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—HRAS—autistic disorder	8.17e-06	5.27e-05	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—HRAS—autistic disorder	8.03e-06	5.18e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—SLC25A12—autistic disorder	7.98e-06	5.15e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—DHCR7—autistic disorder	7.95e-06	5.13e-05	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—HRAS—autistic disorder	7.88e-06	5.08e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—SLC19A1—autistic disorder	7.76e-06	5.01e-05	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—HRAS—autistic disorder	7.74e-06	5e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—autistic disorder	7.71e-06	4.98e-05	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—MAPK1—autistic disorder	7.66e-06	4.94e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—EXT1—autistic disorder	7.54e-06	4.87e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—SLC6A8—autistic disorder	7.54e-06	4.87e-05	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—MAPK1—autistic disorder	7.52e-06	4.85e-05	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—MAPK1—autistic disorder	7.39e-06	4.77e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—DAO—autistic disorder	7.19e-06	4.64e-05	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—HRAS—autistic disorder	7.01e-06	4.52e-05	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—HRAS—autistic disorder	6.92e-06	4.47e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—ADSL—autistic disorder	6.92e-06	4.46e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—UPB1—autistic disorder	6.9e-06	4.45e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—XDH—autistic disorder	6.78e-06	4.38e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—STX1A—autistic disorder	6.66e-06	4.3e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—NPAS2—autistic disorder	6.66e-06	4.3e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—HRAS—autistic disorder	6.6e-06	4.26e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—TCN2—autistic disorder	6.43e-06	4.15e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GSTM5—autistic disorder	6.41e-06	4.14e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—ASMT—autistic disorder	6.41e-06	4.14e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—MAPK1—autistic disorder	6.3e-06	4.07e-05	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—HRAS—autistic disorder	6.15e-06	3.97e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—ADA—autistic disorder	6.13e-06	3.96e-05	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—HRAS—autistic disorder	6.04e-06	3.9e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—SLC25A12—autistic disorder	6.03e-06	3.89e-05	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—HRAS—autistic disorder	5.93e-06	3.83e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—SLC19A1—autistic disorder	5.86e-06	3.78e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—RORA—autistic disorder	5.59e-06	3.61e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	5.39e-06	3.48e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—MAOB—autistic disorder	5.24e-06	3.38e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—ADSL—autistic disorder	5.23e-06	3.37e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—XDH—autistic disorder	5.13e-06	3.31e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—HRAS—autistic disorder	5.06e-06	3.26e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—STX1A—autistic disorder	5.03e-06	3.25e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—NPAS2—autistic disorder	5.03e-06	3.25e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—TPH2—autistic disorder	4.87e-06	3.14e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—TCN2—autistic disorder	4.86e-06	3.14e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—DPYD—autistic disorder	4.79e-06	3.09e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—ADA—autistic disorder	4.64e-06	2.99e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	4.58e-06	2.96e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CACNA1C—autistic disorder	4.46e-06	2.88e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	4.39e-06	2.83e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—RORA—autistic disorder	4.23e-06	2.73e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—DHFR—autistic disorder	4.05e-06	2.62e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—MAOB—autistic disorder	3.96e-06	2.56e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—APOE—autistic disorder	3.77e-06	2.43e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—TPH2—autistic disorder	3.68e-06	2.38e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—DPYD—autistic disorder	3.62e-06	2.34e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	3.4e-06	2.2e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CACNA1C—autistic disorder	3.37e-06	2.17e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—POMC—autistic disorder	3.24e-06	2.09e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CYP19A1—autistic disorder	3.18e-06	2.05e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—DHFR—autistic disorder	3.06e-06	1.98e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—COMT—autistic disorder	2.95e-06	1.9e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GSTP1—autistic disorder	2.94e-06	1.9e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—MAOA—autistic disorder	2.93e-06	1.89e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CAT—autistic disorder	2.86e-06	1.84e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PLA2G4A—autistic disorder	2.7e-06	1.74e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GSTM1—autistic disorder	2.7e-06	1.74e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GPX1—autistic disorder	2.59e-06	1.67e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	2.58e-06	1.67e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CYP19A1—autistic disorder	2.4e-06	1.55e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—MTHFR—autistic disorder	2.39e-06	1.54e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	2.25e-06	1.45e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—COMT—autistic disorder	2.23e-06	1.44e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—APOE—autistic disorder	2.22e-06	1.43e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GSTP1—autistic disorder	2.22e-06	1.43e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—MAOA—autistic disorder	2.22e-06	1.43e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CAT—autistic disorder	2.16e-06	1.39e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GSTM1—autistic disorder	2.04e-06	1.32e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PLA2G4A—autistic disorder	2.04e-06	1.32e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PIK3CG—autistic disorder	2.01e-06	1.29e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GPX1—autistic disorder	1.95e-06	1.26e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—POMC—autistic disorder	1.91e-06	1.23e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—MTHFR—autistic disorder	1.8e-06	1.16e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—APOE—autistic disorder	1.68e-06	1.08e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PTGS2—autistic disorder	1.52e-06	9.82e-06	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PIK3CG—autistic disorder	1.52e-06	9.78e-06	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—POMC—autistic disorder	1.44e-06	9.31e-06	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PTEN—autistic disorder	1.33e-06	8.57e-06	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PTGS2—autistic disorder	1.15e-06	7.42e-06	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PTEN—autistic disorder	1e-06	6.47e-06	CbGpPWpGaD
